BVF PARTNERS L P/IL — SEC insider filings

SEC reporting owner CIK 1055947. 122 insider filings on record with FilingPulse; latest filed 2026-10-05.

Transaction summary — filings shown

Covers the 50 most recent of 122 filings on record, filed 2022-12-22 to 2026-10-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
POINT Biopharma Global Inc. (PNT)—1—3 legs · 17,161,278 sh · $213,657,911—
Kymera Therapeutics, Inc. (KYMR)Director913 legs · 772,279 sh · $20,507,8644 legs · 1,630,658 sh · $173,665,0779
MoonLake Immunotherapeutics (MLTX)Director, 10% owner6—6 legs · 5,750,000 sh · $162,965,7004
XOMA Royalty Corp (XOMA)10% owner64 legs · 22,249 sh · $420,7376 legs · 1,043,440 sh · $27,626,50713
Third Harmonic Bio, Inc. (THRD)—23 legs · 214,063 sh · $879,4993 legs · 1,000,000 sh · $14,300,000—
Olema Pharmaceuticals, Inc. (OLMA)Director73 legs · 1,505,932 sh · $14,818,371—20
Repare Therapeutics Inc. (RPTX)10% owner39 legs · 2,011,010 sh · $9,071,242—3
ESSA Pharma Inc. (EPIX)10% owner2—3 legs · 156 sh · $2939
Eledon Pharmaceuticals, Inc. (ELDN)10% owner36 legs · 3,906,869 sh—12
CTI BIOPHARMA CORP (CTIC)Director, 10% owner2——19

+9 more issuers among the filings shown — every filing appears in the table below.

Insider filings — BVF PARTNERS L P/IL

FiledFormIssuerReported transactionsSource
2026-10-053Foghorn Therapeutics Inc. (FHTX)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Holdings only — no transactions reportedEDGAR
2026-09-184IMMUNIC, INC. (IMUX)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Grant/award (A): 25,370 (derivative) @ $0EDGAR
2026-07-164XOMA Royalty Corp (XOMA)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Code (U): 3,635,758 · Code (U): 2,773,545 · Code (U): 412,000 · Code (U): 772,000EDGAR
2026-06-264Kymera Therapeutics, Inc. (KYMR)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Sale (S): 837,914 @ $106.50 · Sale (S): 627,597 @ $106.50 · Sale (S): 113,289 @ $106.50 · Sale (S): 51,858 @ $106.50EDGAR
2026-06-254Kymera Therapeutics, Inc. (KYMR)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Grant/award (A): 6,068 (derivative) @ $0EDGAR
2026-06-234Olema Pharmaceuticals, Inc. (OLMA)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Grant/award (A): 29,500 (derivative) @ $0EDGAR
2026-06-224MoonLake Immunotherapeutics (MLTX)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Grant/award (A): 22,195 (derivative) @ $0EDGAR
2026-05-184XOMA Royalty Corp (XOMA)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Conversion (C): 2,313,000 @ $4.03 · Conversion (C): 1,506,000 @ $4.03 · Conversion (C): 412,000 @ $4.03 · Conversion (C): 772,000 @ $4.03 · Conversion (C): 2,313 (derivative) @ $0 · Conversion (C): 1,506 (derivative) @ $0 · +2 moreEDGAR
2026-04-024MoonLake Immunotherapeutics (MLTX)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Sale (S): 1,932,354 @ $16.79 · Sale (S): 1,569,116 @ $16.79 · Sale (S): 248,530 @ $16.79EDGAR
2026-01-304Repare Therapeutics Inc. (RPTX)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Code (U): 5,309,432 · Code (U): 4,308,573 · Code (U): 548,938EDGAR
2025-10-144ESSA Pharma Inc. (EPIX)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Code (U): 6,194,145 · Code (U): 4,726,743 · Code (U): 560,797EDGAR
2025-08-074ESSA Pharma Inc. (EPIX)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Option exercise/expiry (X): 1,481,634 @ $0.00 · Option exercise/expiry (X): 1,235,030 @ $0.00 · Option exercise/expiry (X): 203,336 @ $0.00 · Sale (S): 79 @ $1.88 · Sale (S): 66 @ $1.88 · Sale (S): 11 @ $1.88 · +3 moreEDGAR
2025-07-014Kymera Therapeutics, Inc. (KYMR)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Purchase (P): 142,604 @ $44 · Purchase (P): 115,783 @ $44 · Purchase (P): 58,780 @ $44 · Grant/award (A): 16,000 (derivative) @ $0EDGAR
2025-06-174GLYCOMIMETICS INC (CBIO)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Other (J): 657,308 · Other (J): 556,617 · Other (J): 56,079 · Other (J): 304,098 (derivative) · Other (J): 257,515 (derivative) · Other (J): 25,944 (derivative)EDGAR
2025-06-134Olema Pharmaceuticals, Inc. (OLMA)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Grant/award (A): 24,150 (derivative) @ $0EDGAR
2025-06-094MoonLake Immunotherapeutics (MLTX)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Grant/award (A): 6,682 (derivative) @ $0EDGAR
2025-05-204XOMA Royalty Corp (XOMA)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Sale (S): 127,407 @ $27.10 · Sale (S): 265,316 @ $27.10EDGAR
2025-05-194Allakos Inc. (ALLK)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Disposition to issuer (D): 8,679,726 · Disposition to issuer (D): 6,777,935 · Disposition to issuer (D): 855,211EDGAR
2025-01-284XOMA Royalty Corp (XOMA)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Sale (S): 339,679 @ $26.10 · Sale (S): 85,776 @ $26.10 · Sale (S): 75,287 @ $26.10 · Sale (S): 149,975 @ $26.10EDGAR
2025-01-144Olema Pharmaceuticals, Inc. (OLMA)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Disposition to issuer (D): 235,450 · Disposition to issuer (D): 161,810 · Disposition to issuer (D): 22,740 · Grant/award (A): 235,450 (derivative) · Grant/award (A): 161,810 (derivative) · Grant/award (A): 22,740 (derivative)EDGAR
2024-12-174PALVELLA THERAPEUTICS, INC. (PVLA)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Other (J): 234,323 · Other (J): 174,958 · Other (J): 29,648EDGAR
2024-12-044Olema Pharmaceuticals, Inc. (OLMA)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Disposition to issuer (D): 1,797,527 · Disposition to issuer (D): 1,418,736 · Disposition to issuer (D): 153,441 · Grant/award (A): 1,797,527 (derivative) · Grant/award (A): 1,418,736 (derivative) · Grant/award (A): 153,441 (derivative) · +3 moreEDGAR
2024-11-1344D Molecular Therapeutics, Inc. (FDMT)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Other (J): 3,062,000 · Other (J): 2,378,000 · Other (J): 240,000 · Other (J): 3,062,000 (derivative) · Other (J): 2,378,000 (derivative) · Other (J): 240,000 (derivative)EDGAR
2024-10-314Eledon Pharmaceuticals, Inc. (ELDN)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Purchase (P): 2,213,816 (derivative) @ $3.65 · Purchase (P): 2,100,244 (derivative) @ $3.65 · Purchase (P): 440,489 (derivative) @ $3.65EDGAR
2024-10-314Third Harmonic Bio, Inc. (THRD)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Sale (S): 538,420 @ $14.30 · Sale (S): 396,963 @ $14.30 · Sale (S): 64,617 @ $14.30EDGAR
2024-10-084MoonLake Immunotherapeutics (MLTX)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Sale (S): 1,030,589 @ $50.00 · Sale (S): 836,862 @ $50.00 · Sale (S): 132,549 @ $50.00EDGAR
2024-08-224Kymera Therapeutics, Inc. (KYMR)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Purchase (P): 201,546 (derivative) @ $40.75 · Purchase (P): 156,742 (derivative) @ $40.75EDGAR
2024-06-284Kymera Therapeutics, Inc. (KYMR)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Grant/award (A): 16,000 (derivative) @ $0EDGAR
2024-06-184Olema Pharmaceuticals, Inc. (OLMA)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Grant/award (A): 23,000 (derivative) @ $0EDGAR
2024-06-104MoonLake Immunotherapeutics (MLTX)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Grant/award (A): 7,688 (derivative) @ $0EDGAR
2024-05-134Eledon Pharmaceuticals, Inc. (ELDN)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Purchase (P): 1,031,385 · Purchase (P): 821,121 · Purchase (P): 75,431 · Purchase (P): 3,173,135 (derivative) · Purchase (P): 2,526,238 (derivative) · Purchase (P): 232,068 (derivative)EDGAR
2024-01-294Rain Oncology Inc. (RAIN)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Code (U): 1,734,960 · Code (U): 2,870,985 · Code (U): 1,367,838 · Code (U): 2,076,085 · Code (U): 185,388 · Code (U): 341,547 · +2 moreEDGAR
2024-01-094Kymera Therapeutics, Inc. (KYMR)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Purchase (P): 550,425 (derivative) @ $25.25 · Purchase (P): 375,856 (derivative) @ $25.25 · Purchase (P): 52,733 (derivative) @ $25.25EDGAR
2023-12-204POINT Biopharma Global Inc. (PNT)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Sale (S): 8,974,245 @ $12.45 · Sale (S): 7,290,667 @ $12.45 · Sale (S): 896,366 @ $12.45EDGAR
2023-11-174Repare Therapeutics Inc. (RPTX)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Purchase (P): 493,337 @ $5.00 · Purchase (P): 390,507 @ $5.00 · Purchase (P): 47,712 @ $5.00 · Purchase (P): 153,693 @ $5.38 · Purchase (P): 125,909 @ $5.38 · Purchase (P): 16,143 @ $5.38EDGAR
2023-11-064Kymera Therapeutics, Inc. (KYMR)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Purchase (P): 57,618 @ $11.64 · Purchase (P): 132,016 @ $11.64 · Purchase (P): 26,772 @ $11.64 · Purchase (P): 103,885 @ $14.07 · Purchase (P): 83,708 @ $14.07 · Purchase (P): 10,106 @ $14.07EDGAR
2023-11-034Repare Therapeutics Inc. (RPTX)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Purchase (P): 218,979 @ $3.60 · Purchase (P): 492,251 @ $3.60 · Purchase (P): 72,479 @ $3.60EDGAR
2023-09-144Olema Pharmaceuticals, Inc. (OLMA)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Purchase (P): 775,278 @ $9.84 · Purchase (P): 677,853 @ $9.84 · Purchase (P): 52,801 @ $9.84 · Other (J): 99,556EDGAR
2023-06-284CTI BIOPHARMA CORP (CTIC)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Code (U): 3,989,130 @ $9.10 · Code (U): 2,595,239 @ $9.10 · Code (U): 702,505 @ $9.10 · Code (U): 1,526,147 @ $9.10 · Code (U): 43,139 @ $9.10 · Code (U): 1,594 (derivative) · +12 moreEDGAR
2023-06-214Olema Pharmaceuticals, Inc. (OLMA)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Grant/award (A): 21,520 (derivative) @ $0EDGAR
2023-06-204Kymera Therapeutics, Inc. (KYMR)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Grant/award (A): 12,000 (derivative) @ $0EDGAR
2023-06-124MoonLake Immunotherapeutics (MLTX)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Grant/award (A): 11,297 (derivative) @ $0EDGAR
2023-05-194XOMA Corp (XOMA)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Grant/award (A): 10,967 (derivative) @ $0EDGAR
2023-05-124Structure Therapeutics Inc. (GPCR)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Other (J): 4,018,253 · Other (J): 2,929,660 · Other (J): 462,605 · Other (J): 4,018,253 (derivative) · Other (J): 2,929,660 (derivative) · Other (J): 462,605 (derivative)EDGAR
2023-05-094Eledon Pharmaceuticals, Inc. (ELDN)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Purchase (P): 1,055,445 · Purchase (P): 837,146 · Purchase (P): 86,341 · Purchase (P): 2,028,645 (derivative) · Purchase (P): 1,609,063 (derivative) · Purchase (P): 165,950 (derivative) · +3 moreEDGAR
2023-04-074CTI BIOPHARMA CORP (CTIC)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Grant/award (A): 80,000 (derivative) @ $0EDGAR
2023-01-194Cullinan Oncology, Inc. (CGEM)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Other (J): 3,500,000 · Other (J): 2,600,000 · Other (J): 300,000 · Other (J): 350,000 (derivative) · Other (J): 260,000 (derivative) · Other (J): 30,000 (derivative)EDGAR
2023-01-134Kymera Therapeutics, Inc. (KYMR)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Purchase (P): 10,961 @ $29.89 · Purchase (P): 11,149 @ $29.89 · Purchase (P): 2,985 @ $31.24 · Purchase (P): 15,912 @ $31.24EDGAR
2023-01-094XOMA Corp (XOMA)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Purchase (P): 3,330 @ $18.39 · Purchase (P): 1,676 @ $21.98 · Purchase (P): 15,670 @ $18.39 · Purchase (P): 1,573 @ $21.98EDGAR
2022-12-224Third Harmonic Bio, Inc. (THRD)
jointly with BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF INC/IL, LAMPERT MARK N
Purchase (P): 116,635 @ $4.11 · Purchase (P): 87,831 @ $4.11 · Purchase (P): 9,597 @ $4.11EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1055947 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs